Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: Perspectives of service providers

Substance Abuse: Treatment, Prevention, and Policy

Volumn 8, Issue 1, 2013, Pages

  Lang, Katherine ^a   Neil, Jaycie ^b   Wright, Judith ^c   Dell, Colleen A ^b   Berenbaum, Shawna ^b   El Aneed, Anas ^b  

^a REGINA QU APPELLE HEALTH REGION   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Saskatoon City Hospital   (Canada)

Author keywords

Addiction; Focus groups; People who inject drugs (PWID); Qualitative research; Service providers

Indexed keywords

ARTICLE; CANADA; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMATION PROCESSING; MENTAL HEALTH SERVICE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SUBSTANCE ABUSE; UTILIZATION REVIEW;

ATTITUDE OF HEALTH PERSONNEL; CANADA; FOCUS GROUPS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MENTAL HEALTH SERVICES; QUALITATIVE RESEARCH; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84885332878     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/1747-597X-8-35     Document Type: Article

References (47)

1. Vlahov D, Wang CL, Galai N, Bareta J, Mehta SH, Strathdee SA, et al. Mortality risk among new onset injection drug users. Addiction 2004, 99:946-954. 10.1111/j.1360-0443.2004.00780.x, 15265091.
2. Bargagli AM, Sperati A, Davoli M, Forastiere F, Perucci CA. Mortality among problem drug users in Rome: an 18-year follow-up study, 1980-97. Addiction 2001, 96:1455-1463. 10.1046/j.1360-0443.2001.961014559.x, 11571064.
3. Haber PS, Demirkol A, Lange K, Murnion B. Management of injecting drug users admitted to hospital. Lancet 2009, 374:1284-1293. 10.1016/S0140-6736(09)61036-9, 19819393.
4. Contoreggi C, Rexroad VE, Lange WR. Current management of infectious complications in the injecting drug user. J Subst Abuse Treat 1998, 15:95-106. 10.1016/S0740-5472(97)00048-2, 9561947.
5. Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse 1999, 34:727-746. 10.3109/10826089909037240, 10210102.
6. Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend 2006, 81:167-178. 10.1016/j.drugalcdep.2005.06.008, 16043308.
7. Morrison A, Elliott L, Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction 1997, 92:1349-1352. 10.1111/j.1360-0443.1997.tb02853.x, 9489051.
8. Appel PW, Ellison AA, Jansky HK, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Am J Drug Alcohol Abuse 2004, 30:129-153. 10.1081/ADA-120029870, 15083558.
9. Drumm RD, McBride DC, Metsch L, Page JB, Dickerson K, Jones B. " The rock always comes first" : drug users' accounts about using formal health care. J Psychoactive Drugs 2003, 35:461-469. 10.1080/02791072.2003.10400493, 14986875.
10. Gustafson DL, Goodyear L, Keough F. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre. Int J Drug Policy 2008, 19:189-194. 10.1016/j.drugpo.2008.01.005, 18472260.
11. Lally MA, Montstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM. A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care STDS 2008, 22:53-64. 10.1089/apc.2006.0206, 3291496, 18095839.
12. Neale J, Tompkins C, Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community 2008, 16:147-154.
13. Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, O'Shaughnessy MV, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy 2002, 13:95-102.
14. Lang K, El-Aneed A, Berenbaum S, Dell CA, Wright J, McKay ZT. Qualitative assessment of crisis services among persons using injection drugs in the city of Saskatoon. J Subst Use 2011, 18:311.
15. Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend 2007, 88:188-196. 10.1016/j.drugalcdep.2006.10.014, 17118578.
16. McLaughlin DF, McKenna H, Leslie JC. The perceptions and aspirations illicit drug users hold toward health care staff and the care they receive. J Psychiatr Ment Health Nurs 2000, 7:435-441. 10.1046/j.1365-2850.2000.00329.x, 11933470.
17. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the " narc" cabinet. J Gen Intern Med 2002, 17:327-333. 1495051, 12047728.
18. Telfer I, Clulow C. Heroin misusers: what they think of their general practitioners. Br J Addict 1990, 85:137-140. 10.1111/j.1360-0443.1990.tb00633.x, 2310848.
19. Chan KY, Reidpath DD. Stigmatization of patients with AIDS: understanding the interrelationships between thai nurses' attitudes toward HIV/AIDS, drug use, and commercial sex. AIDS Patient Care STDS 2007, 21:763-775. 10.1089/apc.2007.0004, 17949275.
20. Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, Cleary PD. Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med 2005, 165:618-623. 10.1001/archinte.165.6.618, 15795336.
21. Carroll J. Attitudes of professionals to drug abusers. Br J Nurs 1993, 2:705-711. Jul 22-Aug 11.
22. Roche AM, Guray C, Saunders JB. General practitioners' experiences of patients with drug and alcohol problems. Br J Addict 1991, 86:263-275. 10.1111/j.1360-0443.1991.tb01779.x, 2025689.
23. Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Clin Infect Dis 2004, 38:438-441. 10.1086/381095, 14727219.
24. Galea S, Factor SH, Palermo AG, Aaron D, Canales E, Vlahov D. Access to resources for substance users in Harlem, New York city: service provider and client perspectives. Health Educ Behav 2002, 29:296-311. 10.1177/109019810202900303, 12038740.
25. Lewis BA, Koester SK, Bush TW. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc 2002, 42:S46-S51.
26. Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc 2002, 42:S40-S45.
27. Strike CJ, Challacombe L, Myers T, Millson M. Needle exchange programs. Delivery and access issues. Can J Public Health 2002, 93:339-343.
28. Iskandar S, Kamal R, De Jong CA. Psychiatric comorbidity in injecting drug users in Asia and Africa. Curr Opin Psychiatry 2012, 25:213. 10.1097/YCO.0b013e3283523d66, 22449767.
29. de Bruin P, Gibson S, Trischuk H. Saskatoon Health Region HIV Prevention, Treatment & Support Strategy 2010, Saskatoon: Saskatoon Health Region.
30. Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Physicians' Knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health 2007, 84:126-136. 10.1007/s11524-006-9120-z, 2078257, 17146712.
31. Peterson G, Northeast S, Jackson S, Fitzmaurice K. Harm minimization strategies: opinions of health professionals in rural and remote Australia. J Clin Pharm Ther 2007, 32:497-504. 10.1111/j.1365-2710.2007.00857.x, 17875117.
32. Morgan DL. Focus groups as qualitative research vol. 16 1997, Thousand Oaks, CA: Sage Publications, Inc.
33. Lin C, Wu Z, Rou K, Pang L, Cao X, Shoptaw S, et al. Challenges in providing services in methadone maintenance therapy clinics in China: Service providers' perceptions. Int J Drug Policy 2010, 21:173-178. 10.1016/j.drugpo.2009.09.002, 2847064, 19818591.
34. McLaughlin D, McKenna H, Leslie J, Moore K, Robinson J. Illicit drug users in Northern Ireland: perceptions and experiences of health and social care professionals. J Psychiatr Ment Health Nurs 2006, 13:682-686. 10.1111/j.1365-2850.2006.01015.x, 17087670.
35. Pelet A, Besson J, Pécoud A, Favrat B. Difficulties associated with outpatient management of drug abusers by general practitioners. A cross-sectional survey of general practitioners with and without methadone patients in Switzerland. BMC family practice 2005, 6:51. 10.1186/1471-2296-6-51, 1351183, 16364176.
36. Wardman D, Quantz D. Harm reduction services for British Columbia's First Nation population: a qualitative inquiry into opportunities and barriers for injection drug users. Harm Reduction J 2006, 3:30.
37. Deering DEA, Sheridan J, Sellman JD, Adamson SJ, Pooley S, Robertson R, et al. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness. Addictive behaviors 2011, 36:636-642. 10.1016/j.addbeh.2011.01.004, 21276664.
38. Li L, Lin C, Wu Z, Wu S, Rotheram-Borus MJ, Detels R, et al. Stigmatization and shame: consequences of caring for HIV/AIDS patients in China. AIDS Care 2007, 19:258-263. 10.1080/09540120600828473, 2795775, 17364408.
39. Krueger RA, Casey MA. Focus groups: a practical guide for applied research 2009, Thousand Oaks, CA: Sage Publications, Inc.
40. Hausmann LRM, Jeong K, Bost JE, Ibrahim SA. Perceived discrimination in health care and health status in a racially diverse sample. Med Care 2008, 46:905-914. 10.1097/MLR.0b013e3181792562, 3424509, 18725844.
41. Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005, 40(Suppl 5):S276-S285. 1510897, 15768335.
42. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 2003, 114:573-580. 10.1016/S0002-9343(03)00093-7, 12753881.
43. Brener L, Von Hippel W, Kippax S. Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?. Int J Drug Policy 2007, 18:381-387. 10.1016/j.drugpo.2007.01.006, 17854726.
44. Mejta CL, Bokos PJ, Mickenberg J, Maslar ME, Senay E. Improving substance abuse treatment access and retention using a case management approach. J Drug Issues 1997, 27:329-340.
45. Sherer R, Stieglitz K, Narra J, Jasek J, Green L, Moore B, et al. HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care 2002, 14(Suppl 1):S31-S44.
46. Martin N. A time for action tackling stigma and discrimination: report to the Mental Health Commission of Canada 2007, Ottawa, Ontario: Mental Health Commission of Canada.
47. Gibson M, Munn E, Beatty D, Pugh A. Beyond the label 2005, Centre for Addiction and Mental Health.